Alors que l’oncologie interventionnelle (IO) s’affirme comme le 4ème pilier thérapeutique dans la lutte contre le cancer, des étapes importantes sont franchies pour améliorer la prise en charge.
Grâce à l’intelligence artificielle, avec une délimitation de tumeurs hépatiques, couplée à la détection de la zone d’ablation dans une image scanner peropératoire, et sa fusion élastique IRM-scanner, nous avons pu anticiper la localisation de la récidive chez 70% des patients présentant une rechute locale. C’est un succès pour le projet Franco-Suisse Interreg Medical I-Marging (consortium incluant le CHUV et Imactis). La validation clinique se poursuit, avec intégration de la solution dans le workflow de la navigation.
♦ Retrospective, comparative study involving 120 patients
♦ The system demonstrated a very high diagnostic success rate
♦ Radiation exposure & needle insertion time were significantly lower in the navigation group
♦ The use of CT-Navigation is efficient, reliable & safe for lung biopsy compared to conventional CT guidance
M. Lanouzière, O. Varbedian, O. Chevallier, L. Griviau, K. Guillen, R. Popoff, S.-L. Aho-Glélé and R. Loffroy – Diagnostics
♦ Review of the system: description, intended use, procedure details, main benefits and clinical data
♦ CT-Navigation could be considered as a first option in the diagnosis and/or treatment of lesions in difficult locations, even if further studies are necessary
J. A. Gómez Patiño, S. Méndez Alonso, M. Alfageme, R. González Costero, A. García Suárez, J. González Plaza, V. Perdomo Suriel, M. L. Collado Torres – ECR 2020
♦ Phantom study involving 2 operators (junior & senior) and 4 dose reduction protocols
♦ Dose protocol, operator experience, obliquity and target location had no impact on accuracy
♦ The image quality and operator confidence decreased with dose reduction
J. Frandon, P. Akessoul, A. Hamard, E. Bezandry, R. Loffroy, T. Addala, M. Bertrand, J.-P. Beregi, J. Greffier – QIMS
♦ Case review of seven patients: 4 biopsies (hepatic, pulmonary, retroperitoneal and osseous lesions) and 3 ablations (pulmonary, pancreatic and hepatic carcinomas)
♦ The system was easily operated, facilitated pre-procedure planing and displayed an accurate needle trajectory
♦ Benefits for ablations (higher accuracy, better targeting of small lesions) and biopsies (fewer CT controls) without significant post-procedure complications
Yadiel Sánchez, BA, Dmitry S. Trifanov, MD, Taj M. Kattapuram, MD, Haiyang Tao, MD, PhD, Anand M. Prabhakar, MD, MBA, Ronald S. Arellano, MD, Raul N. Uppot, MD – Journal of the American College of Radiology
♦ Prospective controlled multicenter study protocol (500 patients maximum)
♦ The aim is to assess the safety, efficacy and performance within the 2 patient groups
RC. Rouchy, A. Moreau-Gaudry, E. Chipon, S. Aubry, L. Pazart, B. Lapuyade, M. Durand, M. Hajjam, S. Pottier, B. Renard, R. Logier, X. Orry, A. Cherifi, E. Quehen, G. Kervio, O. Favelle, F. Patat, E. De Kerviler, C. Hughes, M. Medici, J. Ghelfi, A. Mounier & I. Bricault – Trials
♦ Prospective controlled study involving 120 patients
♦ Accuracy improved by a factor of 2 (when using the navigation system)
♦ Fewer acquisition scans: 2 vs 3 (when using the navigation system)
